Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.54 |
| ▸ | RELA | Q04206 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HPGDS | O60760 | 2/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.50 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | AKT2 | P31751 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12957108 | 0.93 | HSD17B1 (0.50) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL29578423 | 0.92 | HPGDS (0.58) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL903715 | 0.92 | HPGDS (0.58) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL913315 | 0.92 | HPGDS (0.58) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL12523550 | 0.92 | HPGDS (0.58) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL25118611 | 0.92 | HPGDS (0.58) | NPC1NFKB1RAB9ANFKB2RELA | |
| Iodide SCHEMBL30978328 | 0.90 | HPGDS (0.56) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL500158 | 0.90 | HPGDS (0.56) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL30471908 | 0.90 | HPGDS (0.56) | NPC1NFKB1RAB9ANFKB2RELA | |
| SCHEMBL12973036 | 0.90 | HPGDS (0.60) | NPC1NFKB1RAB9ANFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-8455690-B2 | Method for producing arylhydroxylamine | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-04 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2154125-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | Wako Pure Chemical Industries, Ltd. (JP) | 2010-02-17 | — | — | EP | disclosed |
| US-7361414-B2 | Light emitting device and display apparatus using same | CANON KABUSHIKI KAISHA (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-0813608-B1 | OSMIUM-CONTAINING REDOX MEDIATOR | ROCHE DIAGNOSTICS CORP (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-0813608-A4 | OSMIUM-CONTAINING REDOX MEDIATOR | ROCHE DIAGNOSTICS CORP (US) | 2000-02-09 | — | — | EP | disclosed |
| US-5846702-A | Reagent including an osmium-containing redox mediator | BOEHRINGER MANNHEIM CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0813608-A1 | OSMIUM-CONTAINING REDOX MEDIATOR | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-12-29 | — | — | EP | disclosed |
| US-5589326-A | FOR ELECTROCHEMICAL BIOSENSORS | BOEHRINGER MANNHEIM CORPORATION (US) | 1996-12-31 | — | — | US | disclosed |
| WO-1996025514-A1 | OSMIUM-CONTAINING REDOX MEDIATOR | BOEHRINGER MANNHEIM CORPORATION (US) | 1996-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | PAH, APEH, HPD | NPC1 3771/4885NFKB1 4024/4885RAB9A 1272/4885 |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | NFE2L2, SLC19A2, AOC2 | NPC1 3012/4885NFKB1 2984/4885RAB9A 1148/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | NPC1 1197/4885NFKB1 2899/4885RAB9A 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.